Orphan Drugs Market: Global Industry Outlook, Size (US$ 342.4 Billion), Share, Growth (CAGR of 12.3%), Top Companies Analysis, Research Report 2022-2027
Orphan Drugs Market Trends:
The primary factor driving the global orphan drugs market is the growing research and development (R&D) activities and the rising number of rare diseases lacking treatment. This is further influenced by the arrival of new pharmaceutical drug manufacturers, which has accelerated the introduction of new and effective orphan drugs in the market. Additionally, governments of various countries are encouraging pharmaceutical companies to formulate orphan drugs by providing incentives for drug development, which is acting as another factor propelling the market growth. Other aspects, such as improving access to healthcare, the surging prevalence of genetic disorders and cancer, and the adoption of rare disease therapeutics, are providing an impetus to the market growth.
Download a free sample report to get a detailed overview of the market: https://www.imarcgroup.com/orphan-drugs-market/requestsample
Year Considered to Estimate the Market Size:
Base Year of the Analysis: 2021
Historical Period: 2016-2021
Forecast Period: 2022-2027
Competitive Landscape With Key Players:
The competitive landscape of the orphan drugs market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
• AbbVie Inc.
• Alexion Pharmaceuticals Inc.
• Amgen Inc.
• Biogen Inc.
• Bristol-Myers Squibb Company
• F. Hoffmann-La Roche AG (Roche Holding AG)
• Jazz Pharmaceuticals Plc
• Johnson & Johnson
• Merck & Co. Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi S.A.
• Takeda Pharmaceutical Company Limited
• Teva Pharmaceutical Industries Ltd.
Industry Definition and Application:
Orphan drugs are medications used to treat diseases so rare that sponsors are reluctant to develop them under normal marketing conditions. They are manufactured to meet a specialized health requirement of the public and are used to diagnose and prevent rare and life-threatening diseases or medical disorders. The research on orphan drugs depends on government incentives, which is why they have a limited market and are manufactured for a small group of patients. The drugs are effective against umpteen oncological, immunologic, hematologic, infectious, metabolic, and neurological diseases. They are also used to treat leukemia, glioma, ovarian cancer, pancreatic cancer, lymphoma, cystic fibrosis, multiple renal cell carcinoma, and myeloma.
Key Market Segmentation:
The report has segmented the global orphan drugs market based on drug type, disease type, phase, top selling drugs, distribution channel and region.
Breakup by Drug Type:
Breakup by Disease Type:
Breakup by Phase:
• Phase I
• Phase II
• Phase III
• Phase IV
Breakup by Top Selling Drugs:
Breakup by Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Online Stores
Breakup by Region:
• North America
• Asia Pacific
• Latin America
• Middle East and Africa
Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=2382&flag=C
Note: We are updating our reports, if you want the report with the latest primary and secondary data (2023-2028) including industry trends, market size and competitive landscape, etc. click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form.
Key Highlights of the Report:
• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Orphan Drugs Market: Global Industry Outlook, Size (US$ 342.4 Billion), Share, Growth (CAGR of 12.3%), Top Companies Analysis, Research Report 2022-2027 here
News-ID: 2830522 • Views: 334
More Releases from IMARC Group
Container and Kubernetes Security Market Size Going To Hit US$ 4,469 Million by …
According to IMARC Group's latest report, titled "𝐂𝐨𝐧𝐭𝐚𝐢𝐧𝐞𝐫 𝐚𝐧𝐝 𝐊𝐮𝐛𝐞𝐫𝐧𝐞𝐭𝐞𝐬 𝐒𝐞𝐜𝐮𝐫𝐢𝐭𝐲 𝐌𝐚𝐫𝐤𝐞𝐭: 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗧𝗿𝗲𝗻𝗱𝘀, 𝗦𝗵𝗮𝗿𝗲, 𝗦𝗶𝘇𝗲, 𝗚𝗿𝗼𝘄𝘁𝗵, 𝗢𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝘆 𝗮𝗻𝗱 𝗙𝗼𝗿𝗲𝗰𝗮𝘀𝘁 2023-2028", the container and kubernetes security market reached US$ 1,080 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 4,469 Million by 2028, exhibiting a CAGR of 24.6% during 2023-2028. Container and Kubernetes security represent open-source systems for automating the deployment, management, and scaling of containerized
Carbon Management Software Market to Reach US$ 26.99 Billion by 2028
According to IMARC Group's latest research report, titled "Carbon Management Software Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028," the global carbon management software market size reached US$ 13.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 26.99 Billion by 2028, exhibiting a growth rate (CAGR) of 12.02% during 2023-2028. Get Free Sample Copy of Report at - https://www.imarcgroup.com/carbon-management-software-market/requestsample Carbon Management Software Market Outlook: Carbon
US$ 260.5 Billion, Aquafeed Market Size Rise at +8.9% CAGR by 2028
IMARC Group's latest report, titled "Aquafeed Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028," finds that the global aquafeed market size reached US$ 155.3 Billion in 2022. Looking forward, IMARC Group expects the market value to reach US$ 260.5 Billion by 2028, growing at a CAGR of 8.9% during the forecast period (2023-2028). Request Free Sample Report: https://www.imarcgroup.com/aquafeed-market/requestsample Aquafeed refers to any feed manufactured commercially for aquatic farmed
Colposcopes Market To Reach US$ 841.2 Million by 2028 | Growth Rate (CAGR) of 6. …
According to the latest report by IMARC Group, titled "Colposcopes Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028," the global colposcopes market size reached US$ 594.0 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 841.2 Million by 2028, exhibiting a growth rate (CAGR) of 6.4% during 2023-2028. Colposcopes are medical devices used by gynecologists to closely examine the cervix, and vagina, of
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market. Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: email@example.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: firstname.lastname@example.org or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug